Racial and age-related factors are known to have an impact on lupus severity.12–14 We now show that abnormalities in the complement system and, in particular, classical complement activation as ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
This innovation centers on a bacterial peptide binder conjugated to C3b, a protein that activates the immune system's complement pathway. The researchers demonstrated that this chimeric tag could ...
Inflarx N.V. ( (IFRX) ) has released its Q3 earnings. Here is a breakdown of the information Inflarx N.V. presented to its investors. InflaRx N.V. is a biopharmaceutical company focused on developing ...
The complement system is part of the innate immune system, but can contribute to numerous diseases when it acts errantly, including kidney conditions. Purespring bottles up $105M series B to bring ...